2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | - | - | - | - | 83.812 | 139.458 | 162.452 | 148.806 | 121.559 | 111.622 |
Total Income - EUR | - | - | - | - | 83.836 | 139.458 | 162.907 | 149.673 | 122.084 | 111.728 |
Total Expenses - EUR | - | - | - | - | 87.439 | 140.431 | 149.651 | 143.026 | 125.914 | 120.697 |
Gross Profit/Loss - EUR | - | - | - | - | -3.603 | -973 | 13.256 | 6.647 | -3.830 | -8.969 |
Net Profit/Loss - EUR | - | - | - | - | -4.441 | -2.368 | 11.671 | 5.300 | -5.051 | -10.088 |
Employees | - | - | - | - | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Madymar Pharm Srl
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | - | - | - | - | 1.817 | 1.756 | 1.624 | 16.422 | 27.412 | 19.934 |
Current Assets | - | - | - | - | 28.317 | 23.487 | 33.653 | 32.520 | 30.639 | 24.750 |
Inventories | - | - | - | - | 17.686 | 15.646 | 22.758 | 22.420 | 17.723 | 17.117 |
Receivables | - | - | - | - | 6.935 | 4.608 | 3.843 | 4.981 | 2.790 | 2.843 |
Cash | - | - | - | - | 3.695 | 3.233 | 7.052 | 5.119 | 10.126 | 4.790 |
Shareholders Funds | - | - | - | - | -4.398 | -6.681 | 5.117 | 5.349 | -4.994 | -15.067 |
Social Capital | - | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 |
Debts | - | - | - | - | 34.770 | 33.293 | 31.498 | 43.589 | 63.112 | 59.753 |
Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "4773 - 4773" | |||||||||
CAEN Financial Year |
4773
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Madymar Pharm Srl